RecruitingPhase 4NCT06045754
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
Sponsor: Takeda
Wexford, PA · +40 more sites
1 recruiting crohn's disease studies with a site in Wexford, PA.
Sponsor: Takeda
Wexford, PA · +40 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.